Archives of Gynecology and Obstetrics

, Volume 299, Issue 2, pp 421–430 | Cite as

The impact of antenatal factor XIII levels on postpartum haemorrhage: a prospective observational study

  • Christian BambergEmail author
  • Laura Mickley
  • Anne Henkelmann
  • Katja Niepraschk-von Dollen
  • Lutz Kaufner
  • Christian v. Heymann
  • Wolfgang Henrich
  • Franziska Pauly
Maternal-Fetal Medicine



Postpartum haemorrhage (PPH) is a leading cause of maternal mortality and morbidity. Our aim was to investigate the relationships between antenatal factor XIII (FXIII), fibrinogen levels, and blood loss at childbirth.


This prospective observational study evaluated an unselected cohort of pregnant women admitted for intended vaginal deliveries of singletons at term. To determine clotting factor levels, we obtained blood samples at a maximum of three days prior to vaginal delivery. A calibrated collecting drape was used to quantify blood loss in the third stage of labour. Moderate and severe PPH were diagnosed as blood losses ≥ 500 mL and ≥ 1000 mL, respectively. In a multiple logistic regression analysis, we determined whether coagulation factors and their interactions could independently predict (severe) PPH.


We analysed 548 vaginal deliveries that occurred during the study period. Of those, 78 (14.2%) lost ≥ 500 mL and 18 (3.3%) lost ≥ 1000 mL of blood. The mean pre-delivery FXIII activity in women with PPH (79.33% ± 15.5) was significantly (p < 0.001) lower than in women without PPH (86.45% ± 14.6). A receiver operating characteristic curve analysis detected antenatal FXIII cutoff levels of 83.5% and 75.5% for PPH and severe PPH, respectively. The multiple logistic regression analysis showed that FXIII alone (p < 0.001) and its interaction with fibrinogen (p = 0.03) significantly predicted PPH. FXIII was not significantly correlated with blood loss among patients with severe PPH.


Our results suggested that antenatal FXIII levels may have a significant influence on PPH. The interaction between FXIII and fibrinogen might also provide slight advantages in forecasting PPH.


Factor XIII Fibrinogen Postpartum blood loss Postpartum haemorrhage 


Author contribution

CB: manuscript writing, data analysis, LM: manuscript writing, data collection, AH: data collection, KND: data collection, LK: manuscript editing, CvH: manuscript editing, WH: project development, FP: data analysis.


This study was funded by CSL Behring.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest related to this study. Trial registration: German Clinical Trials Register (7873).

Supplementary material

404_2018_4980_MOESM1_ESM.docx (15 kb)
Supplementary material 1 (docx 15 KB)


  1. 1.
    Kominiarek MA, Kilpatrick SJ (2007) Postpartum hemorrhage: a recurring pregnancy complication. Semin Perinatol 31:159–166CrossRefGoogle Scholar
  2. 2.
    Oyelese Y, Ananth CV (2010) Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 53:147–156CrossRefGoogle Scholar
  3. 3.
    Henrich W, Surbek D, Kainer F et al (2008) Diagnosis and treatment of peripartum bleeding. J Perinat Med 36:467–478CrossRefGoogle Scholar
  4. 4.
    Huq FY, Kadir RA (2011) Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia 17(Suppl 1):20–30CrossRefGoogle Scholar
  5. 5.
    Kadir R, Chi C, Bolton-Maggs P (2009) Pregnancy and rare bleeding disorders. Haemophilia 15:990–1005CrossRefGoogle Scholar
  6. 6.
    Peyvandi F, Garagiola I, Menegatti M (2011) Gynecological and obstetrical manifestations of inherited bleeding disorders in women. J Thromb Haemost 9(Suppl 1):236–245CrossRefGoogle Scholar
  7. 7.
    Gerlach R, Raabe A, Zimmermann M, Siegemund A, Factor Seifert V (2000) XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 54:260–264 (discussion 4–5) CrossRefGoogle Scholar
  8. 8.
    Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V (2002) Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 33:1618–1623CrossRefGoogle Scholar
  9. 9.
    Wettstein P, Haeberli A, Stutz M et al (2004) Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 99:1564–1569 (table of contents) Google Scholar
  10. 10.
    Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16:153–168CrossRefGoogle Scholar
  11. 11.
    Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29:125–130CrossRefGoogle Scholar
  12. 12.
    Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S (2010) Haemostatic reference intervals in pregnancy. Thromb Haemost 103:718–727CrossRefGoogle Scholar
  13. 13.
    Karlsson O, Jeppsson A, Hellgren M (2014) A longitudinal study of factor XIII activity, fibrinogen concentration, platelet count and clot strength during normal pregnancy. Thromb Res 134:750–752CrossRefGoogle Scholar
  14. 14.
    Sharief LT, Lawrie AS, Mackie IJ, Smith C, Peyvandi F, Kadir RA (2014) Changes in factor XIII level during pregnancy. Haemophilia 20:e144–e148CrossRefGoogle Scholar
  15. 15.
    Kaveney AD, Philipp CS (2016) Mild factor XIII deficiency and concurrent hypofibrinogenemia: effect of pregnancy. Blood Coagul Fibrinolysis 27:457–460CrossRefGoogle Scholar
  16. 16.
    Bamberg C, Niepraschk-von Dollen K, Mickley L et al (2016) Evaluation of measured postpartum blood loss after vaginal delivery using a collector bag in relation to postpartum hemorrhage management strategies: a prospective observational study. J Perinat Med 44:433–439CrossRefGoogle Scholar
  17. 17.
    Niepraschk-von Dollen K, Bamberg C, Henkelmann A et al (2016) Predelivery maternal fibrinogen as a predictor of blood loss after vaginal delivery. Arch Gynecol Obstet 294:745–751CrossRefGoogle Scholar
  18. 18.
    Kaufner L, Henkelmann A, von Heymann C et al (2017) Can prepartum thromboelastometry-derived parameters and fibrinogen levels really predict postpartum hemorrhage? J Perinat Med 45:427–435CrossRefGoogle Scholar
  19. 19.
    Kohler HP (2013) Interaction between FXIII and fibrinogen. Blood 121:1931–1932CrossRefGoogle Scholar
  20. 20.
    Organization WH (2012) WHO recommendations for the prevention and treatment of postpartum haemorrhageGoogle Scholar
  21. 21.
    DGGG (2016) Peripartale Blutungen, Diagnostik und Therapie. Deutsche Gesellschaft für Gynäkologie und GeburtshilfeGoogle Scholar
  22. 22.
    Schlembach D, Mortl MG, Girard T et al (2014) Management of postpartum hemorrhage (PPH): algorithm of the interdisciplinary D-A-CH consensus group PPH (Germany–Austria–Switzerland). Anaesthesist 63:234–242CrossRefGoogle Scholar
  23. 23.
    Karimi M, Bereczky Z, Cohan N, Muszbek L (2009) Factor XIII Deficiency. Semin Thromb Hemost 35:426–438CrossRefGoogle Scholar
  24. 24.
    Abdul-Kadir R, McLintock C, Ducloy AS et al (2014) Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion 54:1756–1768CrossRefGoogle Scholar
  25. 25.
    Asahina T, Kobayashi T, Takeuchi K, Kanayama N (2007) Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 62:255–260CrossRefGoogle Scholar
  26. 26.
    Inbal A, Muszbek L (2003) Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost 29:171–174CrossRefGoogle Scholar
  27. 27.
    Chi C, Kadir RA (2012) Inherited bleeding disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol 26:103–117CrossRefGoogle Scholar
  28. 28.
    Sharief LA, Kadir RA (2013) Congenital factor XIII deficiency in women: a systematic review of literature. Haemophilia 19:e349–e357CrossRefGoogle Scholar
  29. 29.
    Hsieh L, Nugent D (2008) Factor XIII deficiency. Haemophilia 14:1190–1200CrossRefGoogle Scholar
  30. 30.
    Cantwell R, Clutton-Brock T, Cooper G et al (2011) Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118(Suppl 1):1–203Google Scholar
  31. 31.
    Bouwmeester FW, Bolte AC, van Geijn HP (2005) Pharmacological and surgical therapy for primary postpartum hemorrhage. Curr Pharm Des 11:759–773CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of ObstetricsCharité-University Medical CenterBerlinGermany
  2. 2.Department of Anaesthesiology and Intensive Care MedicineCharité-University Medical CenterBerlinGermany
  3. 3.Department of Obstetrics and Fetal MedicineUniversity Medical Center Hamburg-EppendorfHamburgGermany

Personalised recommendations